PI
GSK icon

PEAK6 Investments’s GSK GSK Stock Holding History

PEAK6 Investments’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-50,000
Closed -$2.14M – 3876
2024
Q1 		$2.14M Buy
+50,000
New +$2.06M 0.01% 1384
2023
Q4 		– Sell
-48,300
Closed -$1.75M – 4460
2023
Q3 		$1.75M Buy
+48,300
New +$1.71M 0.01% 1423
2023
Q1 		– Sell
-251,200
Closed -$8.83M – 4554
2022
Q4 		$8.83M Buy
251,200
+103,300
+70% +$3.44M 0.05% 432
2022
Q3 		$4.35M Buy
+147,900
New +$5.61M 0.02% 924
2021
Q1 		– Sell
-3,520
Closed -$162K – 5103
2020
Q4 		$162K Sell
3,520
-146,400
-98% -$6.72M ﹤0.01% 3833
2020
Q3 		$7.05M Sell
149,920
-4,720
-3% -$236K 0.02% 767
2020
Q2 		$7.88M Buy
154,640
+145,040
+1,511% +$7.44M 0.03% 583
2020
Q1 		$455K Sell
9,600
-720
-7% -$38.4K ﹤0.01% 2157
2019
Q4 		$606K Sell
10,320
-112,640
-92% -$6.27M ﹤0.01% 1855
2019
Q3 		$6.56M Sell
122,960
-3,280
-3% -$169K 0.04% 540
2019
Q2 		$6.32M Sell
126,240
-51,440
-29% -$2.58M 0.04% 568
2019
Q1 		$9.28M Sell
177,680
-82,560
-32% -$4.13M 0.05% 400
2018
Q4 		$12.4M Sell
260,240
-39,440
-13% -$1.94M 0.08% 270
2018
Q3 		$15M Buy
+299,680
New +$15.2M 0.07% 318

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

PEAK6 Investments's GSK Position: Q1 2024 in Review

PEAK6 Investments sold out of GSK (GSK) in Q1 2024, closing a stake of 1,206 shares — an estimated $49.7K sold.

PEAK6 Investments first reported a position in GSK in Q4 2018 and held it in 7 quarters. The position peaked at $7.29M in Q3 2022. 911 funds tracked by Wall St. Rank hold GSK as of Q1 2024.

  • PEAK6 Investments reported no remaining GSK position as of Q1 2024 after selling out during the quarter.
  • PEAK6 Investments sold 1,206 GSK shares in Q1 2024, an estimated $49.7K.
  • PEAK6 Investments first reported a position in GSK in Q4 2018 and held it in 7 quarters.
  • PEAK6 Investments's GSK position peaked at $7.29M in Q3 2022.
  • 911 funds tracked by Wall St. Rank held GSK as of Q1 2024.

Based on PEAK6 Investments's 13F filing for Q1 2024, filed 14 May 2024.